Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 3 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of TNMD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 97% | 887.38 | 444 / 459 | 32% | 2.39 | 358 / 1118 |
| adipose | 99% | 1192.73 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 68% | 88.00 | 123 / 180 | 13% | 0.73 | 55 / 430 |
| intestine | 23% | 20.80 | 219 / 966 | 45% | 2.43 | 236 / 527 |
| skin | 53% | 122.02 | 956 / 1809 | 5% | 5.48 | 23 / 472 |
| kidney | 22% | 35.58 | 20 / 89 | 25% | 2.36 | 226 / 901 |
| stomach | 1% | 1.00 | 5 / 359 | 32% | 1.50 | 92 / 286 |
| prostate | 17% | 17.29 | 42 / 245 | 15% | 0.34 | 73 / 502 |
| muscle | 27% | 115.50 | 215 / 803 | 0% | 0 | 0 / 0 |
| bladder | 5% | 2.62 | 1 / 21 | 17% | 0.87 | 88 / 504 |
| uterus | 6% | 3.68 | 11 / 170 | 15% | 27.51 | 69 / 459 |
| blood vessel | 21% | 48.66 | 284 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 0 | 0 / 328 | 13% | 0.51 | 23 / 178 |
| brain | 2% | 1.42 | 40 / 2642 | 10% | 1.06 | 73 / 705 |
| thymus | 5% | 3.40 | 32 / 653 | 6% | 0.11 | 34 / 605 |
| heart | 5% | 5.59 | 47 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 2.08 | 5 / 258 | 3% | 0.09 | 7 / 230 |
| lung | 0% | 0.08 | 1 / 578 | 4% | 0.66 | 44 / 1155 |
| esophagus | 3% | 2.84 | 46 / 1445 | 1% | 0.01 | 1 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.27 | 1 / 45 |
| spleen | 1% | 0.44 | 2 / 241 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.01 | 3 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
| GO_0001886 | Biological process | endothelial cell morphogenesis |
| GO_0016525 | Biological process | negative regulation of angiogenesis |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TNMD |
| Protein name | Tenomodulin (TeM) (hTeM) (Chondromodulin-1-like protein) (ChM1L) (hChM1L) (Chondromodulin-I-like protein) (Myodulin) (Tendin) |
| Synonyms | UNQ771/PRO1565 CHM1L |
| Description | FUNCTION: May be an angiogenesis inhibitor. |
| Accessions | ENST00000373031.5 [Q9H2S6-1] Q9H2S6 |